Celgene
Corporate VC
Celgene, now part of Bristol Myers Squibb, was a biopharma company investing in biotech, oncology, and immunology innovations.
Growth
Early Stage
Biotech
Immunology
Oncology
- Headquarters
- Summit, United States
- Website
- bms.com
- Last Investment
- Mar 2018
- Geographic Focus
- United States
Investment Thesis
Celgene, now part of Bristol Myers Squibb, was a biopharma company investing in biotech, oncology, and immunology innovations.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account